Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Dyax Corp DYAX

Sector: Healthcare | Sub-Sector: Biotechnology

Dyax Corp is a biopharmaceutical company focused on Hereditary Angioedema and Other Plasma-Kallikrein-Mediated (PKM)Disorders and Licensing and Funded Research Portfolio.
Price: $27.97 Volume: 1.8m
Change: $-0.46 % Change: -1.62%
Day High/Low: 28.54/27.58 52 Week High/Low: 30.55/6.05
Last Traded: April 17, 2015 12:00 Transaction Volume: 200
Open: 28.20 Previous Close: 28.43
Bid: Ask:
Bid Size: 0 Ask Size: 0
Market Cap: 3.8b Shares Out: 137.1m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts

  • 2,50 USD this week

    0 stars

    and still nobody out there :-)

    0.5 stars


  • Wow - STRONG BUY

    0 stars

    I know that I am more or less alone here - but that is also a good sign. Because with all you people here everybody would already be...

    0.5 stars


  • placed

    0 stars

    it seems to me that the shares have been fully placed (inclusive the additional ones), otherwise the stockquote wouldn't be above the...

    0.5 stars


  • Good news today: Financing by Deutsche Bank

    0 stars

    In these days it isn't easy to get money. So if an investor is willing to sign in at 2.02 USD the company should beworth more ;-)Dyax...

    0.5 stars


  • just buy it

    0 stars

    This company seems to be very interesting for the next days and weeks - first of all there is a drug pending on fda - furthermore the...

    0.5 stars